Stocks and Investing Stocks and Investing
Fri, August 2, 2024

Gregory Renza Maintained (AGIO) at Buy with Increased Target to $55 on, Aug 2nd, 2024


Published on 2024-10-28 13:08:26 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Increased Target from $53 to $55 on, Aug 2nd, 2024.

Gregory has made no other calls on AGIO in the last 4 months.



There are 3 other peers that have a rating on AGIO. Out of the 3 peers that are also analyzing AGIO, 2 agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tessa Romero of "JP Morgan" Initiated at Hold and Held Target at $46 on, Thursday, June 13th, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $53 on, Tuesday, June 4th, 2024


This is the rating of the analyst that currently disagrees with Gregory


  • Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy on, Monday, June 17th, 2024
Contributing Sources